Dr. Christopher Lieu on the 2024 GI Cancers Symposium

Christopher Lieu, MD, Associate Director for Clinical Research and co-Director of Gastrointestinal Medical Oncology at University of Colorado Medicine, gives an overview of some of the top presentations and data to look out for at the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium, including the impact of ctDNA on early-stage colorectal cancer and TACE plus durvalumab for unresectable HCC. He also discusses the importance of the event for researchers and physicians.